Can a video call replace In-Person therapy for stroke recovery?
NCT ID NCT07661849
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a home-based telerehabilitation program (Tele-CPASS) to standard in-person therapy for improving arm and hand function after a stroke. Forty-two recent stroke survivors with arm weakness will be randomly assigned to receive 20 hours of either remote or in-person therapy focused on daily activities. Researchers will measure arm function before, right after, and at 6 and 12 months to see if the remote option works as well.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- telerehabilitation program (Tele-CPASS)
- What this could lead to
- If successful, this could provide a convenient, home-based therapy option that helps stroke survivors regain arm and hand function without needing to travel to a clinic.
- What could go wrong
- This is a small, early-stage study with only 42 participants, so results may not apply to everyone. The remote format may not be as effective as in-person therapy for some individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 42 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Aug 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 21 years or older * Neuroimaging-confirmed stroke within 40 days prior to enrollment * Persistent hemiparesis resulting in impaired upper extremity function, defined by a score of 0 to 3 on the NIH Stroke Scale motor arm item * Able to participate in all study-related activities, including 1-year follow-up * Short Blessed Memory Orientation and Concentration Scale score less than 8 * Able to follow 2-step commands * Montreal Cognitive Assessment (MoCA) score greater than 25 * No upper extremity injury or condition that limited upper extremity use prior to the stroke Exclusion Criteria: * Inability to provide informed consent * Persistent disabling neurologic condition, such as multiple sclerosis, Parkinsonism, amyotrophic lateral sclerosis, or dementia requiring medication * Clinically significant fluctuations in mental status within 72 hours prior to randomization * Active psychosis, psychosis within the prior 2 years, active substance abuse, or prior substance abuse * Dense sensory loss, defined by a score of 3 or 4 on the NIH Stroke Scale sensory item * Ataxia out of proportion to weakness in the affected arm, defined by a score greater than 1 on the NIH Stroke Scale ataxia item * Not expected to survive 12 months because of other illnesses * Pregnancy * Severe aphasia * Receipt of botulinum toxin or expectation of receiving botulinum toxin during the study period
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hemiparesis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Rehabilitation Sciences Complex, University of Texas at El Paso, 3333 N Mesa St, El Paso, TX 79902
RECRUITINGEl Paso, Texas, 79902, United States
-
Texas Tech University Health Sciences Center El Paso - Neurology Clinic
RECRUITINGEl Paso, Texas, 79905, United States
-
University Medical Center of El Paso - Rehabilitation Services
RECRUITINGEl Paso, Texas, 79905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Robot could let stroke patients rehab their hands at home without a therapist
- Moving patterns may help stroke survivors read faster
- Vibrating wearables put stroke walking to the test
- Robot plus electrical stimulation aims to rebuild arm movement after stroke
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next